Published in Perit Dial Int on November 13, 2009
Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44
Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol (2013) 1.20
Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis. Perit Dial Int (2013) 1.14
Encapsulating peritoneal sclerosis: case series from a university center. Korean J Intern Med (2013) 1.01
Histological criteria for encapsulating peritoneal sclerosis - a standardized approach. PLoS One (2012) 0.96
Phenotypes of encapsulating peritoneal sclerosis--macroscopic appearance, histologic findings, and outcome. Perit Dial Int (2013) 0.95
Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study. Perit Dial Int (2014) 0.89
Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Perit Dial Int (2014) 0.87
Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis. Perit Dial Int (2014) 0.87
Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm (2012) 0.83
Incidence and outcome of encapsulating peritoneal sclerosis. Clin Kidney J (2016) 0.79
Morphological Retrospective Study of Peritoneal Biopsies from Patients with Encapsulating Peritoneal Sclerosis: Underestimated Role of Adipocytes as New Fibroblasts Lineage? Int J Nephrol (2015) 0.78
Living with encapsulating peritoneal sclerosis (EPS): the patient's perspective. Perit Dial Int (2014) 0.77
Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study. PLoS One (2014) 0.77
Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis. World J Nephrol (2016) 0.75
Overcoming the Underutilisation of Peritoneal Dialysis. Biomed Res Int (2015) 0.75
American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy. Clin J Am Soc Nephrol (2013) 0.75
Encapsulating Peritoneal Sclerosis - A rare and serious complication of peritoneal dialysis: Case series. J Med Life (2014) 0.75
Is there an end in sight for encapsulating peritoneal sclerosis? Perit Dial Int (2014) 0.75
A case of acute EPS with local cocoon formation in a patient on peritoneal dialysis. CEN Case Rep (2015) 0.75
Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients. PLoS One (2016) 0.75
Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. Sci Rep (2017) 0.75
An intra-abdominal abscess or "rind" as a consequence of peritoneal dialysis-associated pseudomonas peritonitis. Clin Nephrol Case Stud (2013) 0.75
Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center. Clin Exp Nephrol (2015) 0.75
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
Acute renal failure. Lancet (2005) 5.60
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics (2014) 3.52
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med (2013) 2.96
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68
Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant (2010) 2.67
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
Acute kidney injury: an increasing global concern. Lancet (2013) 2.61
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant (2012) 2.59
Acute kidney injury. Lancet (2008) 2.44
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int (2005) 2.42
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Indo-Asian experience of renal transplantation in Yorkshire: results of a 10-year survey. Transplantation (2002) 2.27
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis (2006) 2.09
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis (2005) 2.05
The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol (2006) 2.01
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int (2009) 1.93
Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis (2011) 1.92
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant (2006) 1.90
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int (2002) 1.84
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int (2005) 1.78
Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol (2009) 1.78
Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2013) 1.77
Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis (2002) 1.76
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Clinical practice guidelines for peritoneal access. Perit Dial Int (2010) 1.71
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Incidence of encapsulating peritoneal sclerosis: a single-center experience with long-term peritoneal dialysis in the United States. Perit Dial Int (2011) 1.63
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant (2004) 1.62
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) (2012) 1.61
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med (2005) 1.60
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis (2004) 1.58
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev (2009) 1.58
Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant (2004) 1.56
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol (2006) 1.54
Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis (2010) 1.53
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation (2004) 1.52
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Association of ethnicity and survival in peritoneal dialysis: a cohort study of incident patients in Brazil. Am J Kidney Dis (2013) 1.51
Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant (2010) 1.50
Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int (2008) 1.49
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. Transpl Int (2014) 1.48
Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia. Blood Purif (2010) 1.47
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med (2003) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics (2009) 1.45
Patients' descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int (2002) 1.45
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Nebulized epinephrine for croup in children. Cochrane Database Syst Rev (2011) 1.43
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43
[Assessment and management of cardiovascular disease in patients with chronic kidney disease]. J Bras Nefrol (2010) 1.41
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol (2003) 1.41
Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol (2010) 1.40
European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant (2013) 1.40
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol (2003) 1.38
Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2004) 1.38
Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice. Transplantation (2003) 1.38
Croup in the paediatric emergency department. Paediatr Child Health (2007) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol (2011) 1.36
Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents. Am J Kidney Dis (2010) 1.36
Continuous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial (2003) 1.34
Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int (2006) 1.33
Review article: Hepatitis B and dialysis. Nephrology (Carlton) (2010) 1.32
Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int (2008) 1.32
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int (2011) 1.31
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31